B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction
2020 · Nature Communications · 60 citations
https://doi.org/10.1038/s41467-020-14867-z
T
Taku Yoshiya
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
1.5K
Citations
19
h-index
35
i10-index
Taku Yoshiya is an academic researcher from Peptide Institute (Japan). The author has contributed to research in topics: Chemical Synthesis and Analysis & Click Chemistry and Applications & Carbohydrate Chemistry and Synthesis. The author has an h-index of 19, co-authored 70 publications.
ORCID: 0000-0002-7276-5614Papers by this author
worksThe versatile use of solubilizing trityl tags for difficult peptide/protein synthesis
2019 · Organic & Biomolecular Chemistry · 23 citations
https://doi.org/10.1039/c8ob03098g
Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy
2021 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-020-07760-x
Role of a bacterial glycolipid in Sec-independent membrane protein insertion
2022 · Scientific Reports · 14 citations
https://doi.org/10.1038/s41598-022-16304-1
Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy
2021 · BMC Cancer · 3 citations
https://doi.org/10.1186/s12885-021-07815-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat